Guacetisal
Guacetisal is obtained from the esterification of acetylsalicylic acid with guaiacol which has the potential for chronic bronchitis treatment extracted from patent CN 106866420 A.
Product Specifications
CAS Number
55482-89-8
UNSPSC
12352005
Hazard Statement
H302
Target
Prostaglandin Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/Guacetisal.html
Purity
99.95
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C(OC1=CC=CC=C1OC)C2=CC=CC=C2OC(C)=O
Molecular Formula
C16H14O5
Molecular Weight
286.28
Precautions
P264-P270-P330-P501
References & Citations
[1]Li, Junguang, et al. Guacetisal crystal form compound and its preparation method. CN 106866420 A.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Launched
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
EK247663 96 Well
Cattle HIST1H4A (Histone Cluster 1, H4a) ELISA Kit
Sign In for Pricing
View Details